Barely Significant
← all excerpts

Cholestyramine in hemodialysis: a new approach for hyperphosphatemia management.

Korean J Physiol Pharmacol · 2025 · PMC12198453 · PMID 39910709

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
The present study showed that in the cholestyramine group, the decrease in median serum phosphorus levels was highly significant (p < 0.001): from 6.6 mg/dl at baseline to 4.6 mg/dl at the end of month 2 (end of study).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.